Kathleen C. Raffaele

1.6k total citations
28 papers, 1.0k citations indexed

About

Kathleen C. Raffaele is a scholar working on Pharmacology, Health, Toxicology and Mutagenesis and Plant Science. According to data from OpenAlex, Kathleen C. Raffaele has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Health, Toxicology and Mutagenesis and 6 papers in Plant Science. Recurrent topics in Kathleen C. Raffaele's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Pesticide Exposure and Toxicity (6 papers) and Memory and Neural Mechanisms (5 papers). Kathleen C. Raffaele is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Pesticide Exposure and Toxicity (6 papers) and Memory and Neural Mechanisms (5 papers). Kathleen C. Raffaele collaborates with scholars based in United States, Canada and United Kingdom. Kathleen C. Raffaele's co-authors include David S. Olton, Mark B. Schapiro, Timothy T. Soncrant, James V. Haxby, Sanjay Asthana, Annamaria Berardi, Stanley I. Rapoport, Susan L. Makris, Nigel H. Greig and Kevin M. Crofton and has published in prestigious journals such as Environmental Health Perspectives, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Kathleen C. Raffaele

28 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen C. Raffaele United States	17	329	321	166	152	147	28	1.0k
R. M. Joy United States	18	163 0.5×	637 2.0×	80 0.5×	54 0.4×	290 2.0×	54	956
Tilson Ha United States	15	80 0.2×	280 0.9×	196 1.2×	64 0.4×	158 1.1×	39	927
B.M. Kulig Netherlands	19	154 0.5×	159 0.5×	197 1.2×	45 0.3×	65 0.4×	50	891
Ettie Grauer Israel	19	87 0.3×	335 1.0×	125 0.8×	312 2.1×	282 1.9×	40	1.2k
A. Lévy Israel	16	123 0.4×	269 0.8×	46 0.3×	116 0.8×	224 1.5×	28	799
Perrie M. Adams United States	23	121 0.4×	410 1.3×	200 1.2×	97 0.6×	433 2.9×	55	1.4k
Hideaki Kabuto Japan	22	75 0.2×	631 2.0×	373 2.2×	127 0.8×	476 3.2×	71	2.1k
Ewa Widy‐Tyszkiewicz Poland	20	94 0.3×	230 0.7×	67 0.4×	73 0.5×	206 1.4×	58	1.0k
Taíza H. Figueiredo United States	23	214 0.7×	573 1.8×	200 1.2×	282 1.9×	277 1.9×	45	1.3k
Katherine L. McDaniel United States	16	54 0.2×	133 0.4×	295 1.8×	80 0.5×	101 0.7×	44	855

Countries citing papers authored by Kathleen C. Raffaele

Since Specialization

Citations

This map shows the geographic impact of Kathleen C. Raffaele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen C. Raffaele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen C. Raffaele more than expected).

Fields of papers citing papers by Kathleen C. Raffaele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen C. Raffaele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen C. Raffaele. The network helps show where Kathleen C. Raffaele may publish in the future.

Co-authorship network of co-authors of Kathleen C. Raffaele

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen C. Raffaele. A scholar is included among the top collaborators of Kathleen C. Raffaele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen C. Raffaele. Kathleen C. Raffaele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makris, Susan L., Andrew D. Kraft, Ambuja S. Bale, et al.. (2015). Evaluation of the ToxRTool’s ability to rate the reliability of toxicological data for human health hazard assessments. Regulatory Toxicology and Pharmacology. 72(1). 94–101. 21 indexed citations

Mundy, William R., Stephanie Padilla, Joseph M. Breier, et al.. (2015). Expanding the test set: Chemicals with potential to disrupt mammalian brain development. Neurotoxicology and Teratology. 52(Pt A). 25–35. 74 indexed citations

Youngstrom, Eric A., Lauren Kenworthy, Paul H. Lipkin, et al.. (2011). A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES). Neurotoxicology and Teratology. 33(3). 354–359. 14 indexed citations

Raffaele, Kathleen C., et al.. (2010). The use of developmental neurotoxicity data in pesticide risk assessments. Neurotoxicology and Teratology. 32(5). 563–572. 50 indexed citations

Raffaele, Kathleen C., et al.. (2008). Determining normal variability in a developmental neurotoxicity test A report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicology and Teratology. 30(4). 288–325. 18 indexed citations

Makris, Susan L., Kathleen C. Raffaele, Sandra L. Allen, et al.. (2008). A Retrospective Performance Assessment of the Developmental Neurotoxicity Study in Support of OECD Test Guideline 426. Environmental Health Perspectives. 117(1). 17–25. 116 indexed citations

Asthana, Sanjay, Kathleen C. Raffaele, Nigel H. Greig, et al.. (1999). Neuroendocrine Responses to Intravenous Infusion of Physostigmine in Patients with Alzheimer Disease. Alzheimer Disease & Associated Disorders. 13(2). 102–108. 9 indexed citations

Slikker, William, et al.. (1997). Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals.. PubMed. 17(3-4). 825–36. 13 indexed citations

Raffaele, Kathleen C.. (1996). Differential Response to the Cholinergic Agonist Arecoline among Different Cognitive Modalities in Alzheimer's Disease. Neuropsychopharmacology. 15(2). 163–170. 34 indexed citations

10.

Asthana, Sanjay, Nigel H. Greig, Harold W. Holloway, et al.. (1996). Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease*. Clinical Pharmacology & Therapeutics. 60(3). 276–282. 55 indexed citations

11.

Asthana, Sanjay, Kathleen C. Raffaele, Annamaria Berardi, et al.. (1995). Treatment of Alzheimer Disease by Continuous Intravenous Infusion of Physostigmine. Alzheimer Disease & Associated Disorders. 9(4). 223–232. 15 indexed citations

12.

Asthana, Sanjay, Kathleen C. Raffaele, Nigel H. Greig, et al.. (1995). Neuroendocrine responses to intravenous infusion of arecoline in patients with Alzheimer's disease. Psychoneuroendocrinology. 20(6). 623–636. 18 indexed citations

13.

Asthana, Sanjay, et al.. (1995). Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease*. Clinical Pharmacology & Therapeutics. 58(3). 299–309. 50 indexed citations

14.

Soncrant, Timothy T., Kathleen C. Raffaele, Sanjay Asthana, et al.. (1993). Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease. Psychopharmacology. 112(4). 421–427. 58 indexed citations

15.

Haxby, James V., Kathleen C. Raffaele, Jane Gillette, Mark B. Schapiro, & Stanley I. Rapoport. (1992). Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. Journal of clinical and experimental neuropsychology. 14(4). 575–592. 84 indexed citations

16.

Raffaele, Kathleen C., Annamaria Berardi, Pearse Morris, et al.. (1991). Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the alzheimer type. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(5). 643–648. 17 indexed citations

17.

Raffaele, Kathleen C., D.S. Olton, & Zoltan Annau. (1990). Repeated exposure to diisopropylfluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal. Psychopharmacology. 100(2). 267–274. 16 indexed citations

18.

Raffaele, Kathleen C. & David S. Olton. (1988). Hippocampal and amygdaloid involvement in working memory for nonspatial stimuli.. Behavioral Neuroscience. 102(3). 349–355. 131 indexed citations

19.

Raffaele, Kathleen C. & David S. Olton. (1988). Hippocampal and amygdaloid involvement in working memory for nonspatial stimuli.. Behavioral Neuroscience. 102(3). 349–355. 125 indexed citations

20.

Raffaele, Kathleen C., et al.. (1987). Long-term behavioral changes in rats following organophosphonate exposure. Pharmacology Biochemistry and Behavior. 27(3). 407–412. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact